Critical Alerts For Regeneron Pharmaceuticals, Oracle, Edwards Lifesciences Released By InvestorsObserver

Loading...
Loading...

CHICAGO, March 17, 2015 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for REGN, ORCL, EW.

To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. (Note: You may have to copy this link into your browser then press the [ENTER] key.)

REGN: http://www.investorsobserver.com/pr/31620155/REGN
ORCL: http://www.investorsobserver.com/pr/31620155/ORCL
EW: http://www.investorsobserver.com/pr/31620155/EW

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

Today's PriceWatch Alerts cover the following stocks: Regeneron Pharmaceuticals REGN, Oracle ORCL, Edwards Lifesciences EW. InvestorsObserver's PriceWatch Alerts contain concise, detailed strategies for each stock we cover, including position protection tactics designed to defend investors from potential market shifts. While many other market reports only provide stock news and opinion, we offer strategies that can bulwark investments against uncertainty and increase chances of making a profit, even if a stock goes down.

"We go above and beyond typical market coverage," said Bobby Raines, Analyst at InvestorsObserver. "Trading experts and beginning investors alike can find value in our PriceWatch Alerts. We provide actionable strategies that protect investments with basic hedging tactics, along with a concise explanation of our techniques."

InvestorsObserver.com is an online newsletter which focuses on the U.S. equities and options markets. Our analytical tools, screening techniques, rigorous research methods and committed staff provide solid information to help subscribers make the best possible investment decisions. For more information go to www.investorsobserver.com.

All stocks and options shown are examples only-- not recommendations to buy or sell. Our picks do not represent a positive or negative outlook on any security. Potential returns do not take into account your trade size, brokerage commissions or taxes--expenses that will affect actual investment returns. Stocks and options involve risk, thus they are not suitable for all investors. Prior to buying or selling options, a person should request a copy of Characteristics and Risks of Standardized Options available at http://www.cboe.com/Resources/Intro.aspx. Privacy policy available upon request.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/critical-alerts-for-regeneron-pharmaceuticals-oracle-edwards-lifesciences-released-by-investorsobserver-300051509.html

SOURCE InvestorsObserver

Loading...
Loading...
Posted In: Press Releases
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...